ruxolitinib 15 MG (as ruxolitinib phosphate 19.8 MG) per 1 GM Topical Cream
- RxCUI
- 2570752
- RxNorm name
- ruxolitinib 15 MG (as ruxolitinib phosphate 19.8 MG) per 1 GM Topical Cream
- Display name
- ruxolitinib 15 MG (as ruxolitinib phosphate 19.8 MG) per 1 GM Topical Cream
- Full name
- ruxolitinib 15 MG (as ruxolitinib phosphate 19.8 MG) per 1 GM Topical Cream
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OPZELURA | RUXOLITINIB | Incyte Corporation | 24da5509-6631-4795-9d42-273faecd08e7 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 2570752 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 24da5509-6631-4795-9d42-273faecd08e7 | ruxolitinib 15 MG (as ruxolitinib phosphate 19.8 MG) per 1 GM Topical Cream | SY | 13 | These highlights do not include all the information needed to use OPZELURA cream safely and effectively. See full prescribing information for OPZELURA cream. OPZELURA ® (ruxolitinib) cream, for topical use Initial U.S. Approval: 2011 | 20251111 |
| 24da5509-6631-4795-9d42-273faecd08e7 | ruxolitinib 15 MG/ML Topical Cream | PSN | 13 | These highlights do not include all the information needed to use OPZELURA cream safely and effectively. See full prescribing information for OPZELURA cream. OPZELURA ® (ruxolitinib) cream, for topical use Initial U.S. Approval: 2011 | 20251111 |
| 24da5509-6631-4795-9d42-273faecd08e7 | ruxolitinib 1.5 % Topical Cream | SY | 13 | These highlights do not include all the information needed to use OPZELURA cream safely and effectively. See full prescribing information for OPZELURA cream. OPZELURA ® (ruxolitinib) cream, for topical use Initial U.S. Approval: 2011 | 20251111 |
| 24da5509-6631-4795-9d42-273faecd08e7 | ruxolitinib 15 MG/ML Topical Cream | SCD | 13 | These highlights do not include all the information needed to use OPZELURA cream safely and effectively. See full prescribing information for OPZELURA cream. OPZELURA ® (ruxolitinib) cream, for topical use Initial U.S. Approval: 2011 | 20251111 |